Recruiting
Early Phase 1

Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease

Sponsor:

State University of New York - Upstate Medical University

Code:

NCT06611111

Conditions

Post-Treatment Lyme Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ceftriaxone (Rocephin®)

Dextrose 5% (D5W)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information